Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer.

Walters, R S

Phase II study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer. [electronic resource] - Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy Oct 1995 - 185-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

1067-5582

10.1097/00002371-199510000-00006 doi


Adult
Aged
Bone Marrow--drug effects
Breast Neoplasms--drug therapy
Combined Modality Therapy
Female
Fluorouracil--administration & dosage
Humans
Immunotherapy
Infusions, Intravenous
Injections, Subcutaneous
Interferon Type I--administration & dosage
Middle Aged
Recombinant Proteins